Pharmacoepidemiology is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2022. The journal covers Therapeutics. Pharmacology, Other systems of medicine, and Public aspects of medicine.
Authors are required to pay an article processing charge to publish in Pharmacoepidemiology; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Pharmacoepidemiology has published 109 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
molecular pharmacoepidemiology, the methodology of pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, clinical pharmacology, epidemiology
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2813-0618
Frequently asked questions
Is Pharmacoepidemiology peer-reviewed?
Does Pharmacoepidemiology charge an article processing charge (APC)?
What subjects does Pharmacoepidemiology publish?
What languages does Pharmacoepidemiology accept?
What is the ISSN of Pharmacoepidemiology?
2813-0618 (electronic).